Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Fulda

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
Oncotarget|September 9, 2017
Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell linesLilly Magdalena WeiΔ, Manuela Hugle, Simone Fulda
Oncotarget|January 21, 2016
Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cellsStefanie Roesler, Ines Eckhardt, Sebastian Wolf, et al.
British Journal of Cancer|March 24, 2020
A direct comparison of selective BH3-mimetics reveals BCL-X<sub>L</sub>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastomaAnnika Bierbrauer, Maureen Jacob, Meike Vogler, et al.
Cancer Research|February 14, 2018
<i>NRAS</i>-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K<b>α</b>Nadezda Dolgikh, Manuela Hugle, Meike Vogler, et al.
Biochemical Pharmacology|January 18, 2016
Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasisChristina Haß, Katharina Belz, Hannah Schoeneberger, et al.
Cancer Letters|February 26, 2016
Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosisMichael Reiter, Ines Eckhardt, Axel Haferkamp, et al.
Biochemical Pharmacology|June 10, 2017
Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell deathLukas Probst, Jasmin Dächert, Barbara Schenk, et al.
Oncotarget|September 3, 2016
RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell deathJasmin Dächert, Hannah Schoeneberger, Katharina Rohde, et al.
Cell Death & Disease|December 6, 2019
Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AMLLarissa Ewald, Jessica Dittmann, Meike Vogler, et al.
Cancer Letters|July 19, 2017
Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cellsIrfan Ahmed Bhatti, Behnaz Ahangarian Abhari, Simone Fulda
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
Oncotarget|September 9, 2017
Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell linesLilly Magdalena WeiΔ, Manuela Hugle, Simone Fulda
Oncotarget|January 21, 2016
Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cellsStefanie Roesler, Ines Eckhardt, Sebastian Wolf, et al.
British Journal of Cancer|March 24, 2020
A direct comparison of selective BH3-mimetics reveals BCL-X<sub>L</sub>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastomaAnnika Bierbrauer, Maureen Jacob, Meike Vogler, et al.
Cancer Research|February 14, 2018
<i>NRAS</i>-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K<b>α</b>Nadezda Dolgikh, Manuela Hugle, Meike Vogler, et al.
Biochemical Pharmacology|January 18, 2016
Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasisChristina Haß, Katharina Belz, Hannah Schoeneberger, et al.
Cancer Letters|February 26, 2016
Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosisMichael Reiter, Ines Eckhardt, Axel Haferkamp, et al.
Biochemical Pharmacology|June 10, 2017
Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell deathLukas Probst, Jasmin Dächert, Barbara Schenk, et al.
Oncotarget|September 3, 2016
RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell deathJasmin Dächert, Hannah Schoeneberger, Katharina Rohde, et al.
Cell Death & Disease|December 6, 2019
Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AMLLarissa Ewald, Jessica Dittmann, Meike Vogler, et al.
Cancer Letters|July 19, 2017
Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cellsIrfan Ahmed Bhatti, Behnaz Ahangarian Abhari, Simone Fulda
Pageof 29